ATLASAquestive Therapeutics (AQST) earnings date: Nov 3, 2026
Aquestive Therapeutics (AQST) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of -$0.10.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AQST
| Last price | $3.71 (-4.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Aquestive Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Aquestive Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Aquestive Therapeutics. You can switch it off at any time.
Alert me before AQST reportsFree to start. Creating an account takes under a minute.
Notify me when Aquestive Therapeutics reports
Track AQST free Add Aquestive Therapeutics to a free ATLAS watchlist and see its next report date in one place.
AQST earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.10 |
| Last report | Aug 11, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +18.1% |
| Average move around a report | ±7.6% (last 4) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Aquestive Therapeutics earnings history: last 4 reports
Aquestive Therapeutics last reported on Aug 11, 2026: EPS of -$0.07 against an estimate of -$0.12 (+41.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.12 | -$0.07 | +41.7% | Beat | -1.4% |
| Jun 25, 2026 | -$0.14 | -$0.16 | -14.3% | Miss | -12.0% |
| May 13, 2026 | -$0.13 | -$0.05 | +61.5% | Beat | +13.7% |
| Mar 4, 2026 | -$0.12 | -$0.14 | -16.7% | Miss | +3.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AQST
See the fair value, the probability range and the earnings history of Aquestive Therapeutics on its ATLAS page.
Aquestive Therapeutics (AQST) stock analysisPlans from €3.99 a month.
Aquestive Therapeutics earnings: frequently asked questions
When does Aquestive Therapeutics (AQST) report earnings?
Aquestive Therapeutics is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AQST?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.10 per share (USD). Estimates can change before the report.
How often does AQST beat earnings estimates?
Of its last 4 reports with a recorded result, Aquestive Therapeutics beat the EPS estimate 2 times; the average surprise was +18.1%. Past results do not predict the next one.
How much does AQST move around earnings?
Over its last 4 reports the stock moved an average of 7.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Aquestive Therapeutics beat earnings estimates last quarter?
Aquestive Therapeutics last reported on Aug 11, 2026: EPS of -$0.07 against an estimate of -$0.12 (+41.7% surprise), a beat.
How much does AQST usually move in a day?
On a normal trading day the ATLAS model puts AQST’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer